N-BOC-3-hydroxypiperidine (Lilaliptin for diabetes)

Founded in 2003 and based in Minhang District, Shanghai, Shanghai Record Pharmaceuticals Co., Ltd. (recordpharm.com.cn) manufactures and exports active pharmaceutical ingredients and specialty intermediates. Its finished-API catalog includes pimobendan, trilostane, entecavir, repaglinide, varenicline, zofenopril, sarpogrelate, cilostazol, prasugrel, and the beta-lactam antibiotics carumonam, biapenem and aztreonam, while its intermediate portfolio supports the synthesis of drugs such as loxoprofen sodium, ritonavir, citalopram/escitalopram, duloxetine, azelnidipine and zofenopril calcium. Offering CMO and CDMO contract services under OEM, ODM and its own brand, the company positions itself on internationally recognized certification, experienced R&D personnel, delivery speed and service reputation, selling across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.